Global Enoxaparin Sodium Market is experiencing strong growth, expanding at a 7.7% CAGR from 2025 to 2032. Valued at USD 3,027 million in 2024, the market is set to reach USD 5,111 million by 2032, driven by rising global incidence of thrombotic disorders, increasing surgical procedures, and growing adoption in acute coronary syndrome management.Enoxaparin Sodium—a widely used low molecular weight heparin (LMWH)—plays a vital role in preventing and treating DVT, PE, maintaining catheter patency during dialysis, and supporting thromboprophylaxis in oncology and pregnancy-related complications.
Explore how managed analytics services help enterprises improve data quality, governance,...
Congniflo is a daily dietary supplement formulated to support memory, focus, mental clarit...
Casino Non AAMS: Guida Completa per Comprendere il Funzionamento e Scegliere la Piattaform...